Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone
- PMID: 14962810
- DOI: 10.1016/j.bone.2003.09.010
Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone
Abstract
Glucocorticoids have marked effects on bone metabolism, and continued exposure of skeletal tissue to excessive amounts of these steroids results in osteoporosis. Therefore, in the present proteomic study, we characterized the potential effects of glucocorticoids on protein expression in human osteoblastic cells. Using two-dimensional gel electrophoresis and mass spectrometry, we identified an increased expression of glutamine synthetase (GS) in dexamethasone (Dex)-treated human MG-63 osteosarcoma cells. GS is an enzyme catalyzing the conversion of glutamate and ammonia to glutamine. Intracellular and extracellular glutamate levels may be important in cell signalling mediated by glutamate transporters and receptors which have recently been found in bone cells. The induction of GS protein by Dex was accompanied by an increase in mRNA level and enzyme activity. Dex induction of GS was also mediated by glucocorticoid receptors (GRs) because it was blocked by the GR antagonist RU-38486. In addition, Dex induction of GS expression was partially blocked by cyclohexamide indicating that it at least partly required new protein synthesis. GS induction by Dex was not associated with apoptosis as determined by Bax/Bcl-2 ratio and DNA staining. In addition to MG-63 cells, Dex induction of GS was also observed in human G-292 osteosarcoma cells as well as conditionally immortalized human preosteoblastic (HOB-03-C5) and mature osteoblastic (HOB-03-CE6) cells. However, in two other human osteosarcoma cell lines, SaOS-2 and U2-OS, GS expression was not affected by Dex. This observation may be explained by the lower levels of GR protein in these cells. In summary, this is the first report of the regulation of GS expression by glucocorticoids in bone cells. The role of GS in bone cell metabolism and glucocorticoid action on the skeleton is not yet known, but as a modulator of intracellular glutamate and glutamine levels, it may have an important role in these processes.
Similar articles
-
Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells.Bone. 2008 Sep;43(3):483-93. doi: 10.1016/j.bone.2008.04.016. Epub 2008 May 7. Bone. 2008. PMID: 18555765
-
Glutamine synthetase induction by glucocorticoids in the glucocorticoid-sensitive human leukemic cell line CEM-C7.J Cell Physiol. 1982 Feb;110(2):155-60. doi: 10.1002/jcp.1041100208. J Cell Physiol. 1982. PMID: 6121820
-
Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.J Cell Biochem. 1992 Dec;50(4):411-24. doi: 10.1002/jcb.240500410. J Cell Biochem. 1992. PMID: 1469072
-
Glucocorticoid-mediated induction of glutamine synthetase in skeletal muscle.Med Sci Sports Exerc. 1990 Jun;22(3):325-30. Med Sci Sports Exerc. 1990. PMID: 1974319 Review.
-
Molecular control of glutamine synthetase expression in the developing retina tissue.Dev Dyn. 1993 Apr;196(4):276-82. doi: 10.1002/aja.1001960410. Dev Dyn. 1993. PMID: 8106020 Review.
Cited by
-
Rapid Screening of Glucocorticoid Receptor (GR) Effectors Using Cortisol-Detecting Sensor Cells.Int J Mol Sci. 2021 Apr 29;22(9):4747. doi: 10.3390/ijms22094747. Int J Mol Sci. 2021. PMID: 33947115 Free PMC article.
-
Glutamate signaling in healthy and diseased bone.Front Endocrinol (Lausanne). 2012 Jul 19;3:89. doi: 10.3389/fendo.2012.00089. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22833735 Free PMC article.
-
Research models and mesenchymal/epithelial plasticity of osteosarcoma.Cell Biosci. 2021 May 22;11(1):94. doi: 10.1186/s13578-021-00600-w. Cell Biosci. 2021. PMID: 34022967 Free PMC article. Review.
-
Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.Blood. 2015 Oct 8;126(15):1770-6. doi: 10.1182/blood-2015-05-643601. Epub 2015 Aug 11. Blood. 2015. PMID: 26265699 Free PMC article.
-
A Novel Prenylflavonoid Icariside I Ameliorates Estrogen Deficiency-Induced Osteoporosis via Simultaneous Regulation of Osteoblast and Osteoclast Differentiation.ACS Pharmacol Transl Sci. 2023 Jan 13;6(2):270-280. doi: 10.1021/acsptsci.2c00192. eCollection 2023 Feb 10. ACS Pharmacol Transl Sci. 2023. PMID: 36798476 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous